Status:
COMPLETED
The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women
Lead Sponsor:
Oklahoma State University
Conditions:
Cardiovascular Risk Factor
Menopause Related Conditions
Eligibility:
FEMALE
45-65 years
Phase:
NA
Brief Summary
Given the heightened cardiovascular disease (CVD) risk in post-menopausal women, studies are needed to explore novel, feasible methods for reducing risk in this population. Based on prior data, primar...
Detailed Description
The number of women living with cardiovascular disease (CVD) is greater than for men and CVD is the leading cause of death for women. Post-menopausal women are a particularly vulnerable population in ...
Eligibility Criteria
Inclusion
- provide written and dated informed consent to participate in the study; (2) be willing and able to comply with the protocol
- be willing and able to comply with the protocol
- be a female between the ages of 45 and 65, inclusive
- be postmenopausal for ≥ 1 year
- be in good health and free from chronic cardiovascular, pulmonary, or musculoskeletal disease as determined by a health history questionnaire
- have a BMI between 18.5 and 40.0, inclusive; and
- answer no to all questions on the PAR-Q for people aged 15 to 69, which are as follows:
- Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended by a doctor?
- Do you feel pain in your chest when you do physical activity?
- In the past month, have you had chest pain when you were not doing physical activity?
- Do you lose your balance because of dizziness or do you ever lose consciousness?
- Do you have a bone or joint problem that could be made worse by a change in physical activity?
- Is your doctor currently prescribing drugs for your blood pressure or heart condition? Do you know of any other reason why you should not do physical activity?
Exclusion
- are currently prescribed and/or taking lipid-lowering medications
- are participating in another clinical trial within thirty days prior to enrollment
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 22 2019
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT03752060
Start Date
January 15 2019
End Date
November 22 2019
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
192 Colvin Recreation Center
Stillwater, Oklahoma, United States, 74074